ArticleInternational journal of molecular sciences2025

Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study.

Ji-Hee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.